A primer and probe combination, kit, detection method and application for detecting human-derived components based on RPA technology
Through the combination of primers and probes based on RPA technology, combined with real-time fluorescent recombinase polymerization and amplification technology, the problems of long reaction time and high equipment requirements in the existing technology are solved, and the fields of forensic science and food safety are realized. fast, accurate and sensitive detection effect.
Patent Information
- Application Number
- CN202211186842.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-27
- Publication Date
- 2024-12-20
- Estimated Expiration
- 2042-09-27
AI Technical Summary
The prior art has problems such as long reaction time, high equipment requirements and complex operation in the fields of criminal investigation and food safety. Especially in forensic science, the rapid and accurate identification of low-template samples is difficult to achieve.
Using the combination of primers and probes based on RPA technology, we design the 148bp sequence of the Cytb gene targeting the human mitochondrial genome, and build a high sensitivity RPA system, combining real-time fluorescent recombinase polymerization and amplification technology to achieve rapid detection of human components under constant temperature conditions. .
The sample detection is achieved within 20 minutes, with a sensitivity of 0.003125ng, which is simple to operate and is suitable for rapid, accurate and sensitive species identification in the fields of forensics and food safety.
Smart Images

Figure HDA0003867607580000011 
Figure HDA0003867607580000012 
Figure HDA0003867607580000021
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of molecular biology, and specifically relates to a primer and probe combination, a kit, a detection method and an application for detecting human-derived components based on RPA technology. Background Art
[0002] The determination of human components in samples is of great significance in criminal investigations, food safety and other fields. In the field of forensic medicine, at the scene of a criminal case or in a large-scale disaster event, the identification of human components is very helpful for the progress of the case. The traditional way to identify species is immunological experiments, which detect species-specific proteins based on antigen-antibody reactions, and can also distinguish between human and non-human bones through histological methods. Compared with traditional methods, species identification methods based on DNA molecules are more accurate and are powerful tools for species identification. Compared with the nuclear genome, the copy number of mitochondria in cells is higher, so the focus of species identification is on the detection of mitochondrial regions. At present, a variety of technologies for detecting mitochondrial genomes have been developed, but most of them are based on PCR, and conventional PCR technology requires a certain heating and cooling process, the reaction time is long, and amplification and subsequent detection often require more complex instruments and equipment and operation steps. Therefore, it is urgent to develop a detection method that can quickly identify species. Summary of the invention
[0003] In view of the above-mentioned deficiencies in the prior art, the present invention provides a primer and probe combination, a kit, a detection method and an application for detecting human-derived components based on RPA technology. The present invention designs a set of RPA primers and fluorescent probes based on a partial sequence on the Cytb gene of the human mitochondrial genome. The sensitivity of the constructed RPA system can reach 0.003125ng, and it has good species specificity. The method is simple to operate and takes a short time. The sample can be tested within 20 minutes. It can be used to judge the human-derived components of low-template samples in forensic medicine, and it also provides a complete set of rapid, accurate and sensitive detection methods for forensic species identification.
[0004] To achieve the above purpose, the technical solution adopted by the present invention to solve the technical problem is:
[0005] A primer and probe combination for human-derived component analysis, wherein the primer is designed based on a species-specific 148bp sequence on the Cytb gene of the human mitochondrial genome; the probe is designed for the 148bp sequence on the selected Cytb gene.
[0006] The nucleotide sequences of the primers are shown in SEQ ID NO. 1 and 2; there is an overlap of at least 10 bases between the 5' end of the probe and the above primer pair. The specific sequences of the primers are as follows:
[0007] Upstream primer: 5'-CCTATTACTATCCATCCTCATCCTAGCAAT-3'; (SEQ ID NO.1)
[0008] Downstream primer: 5'-CTAGGAGTCAATAAAGTGATTGGCTTAGTG-3'. (SEQ ID NO.2)
[0009] Furthermore, there is an overlap of 13 bases between the 5' end of the probe and the primer pair.
[0010] Furthermore, the 3' end of the probe is labeled with a modification group, the non-overlapping region of the probe is labeled with tetrahydrofuran 15 nt away from the 3' end, the upstream T base of the tetrahydrofuran is labeled with a fluorescent group, and the downstream T base is labeled with a quenching group.
[0011] Furthermore, the modification group at the 3' end is C3-spacer, the fluorescent group is FAM, and the quenching group is BHQ1.
[0012] Furthermore, the probe length is 46 nt, and the specific sequence is as follows:
[0013] 5'-TCATCCTAGCAATAATCCCCATCCTCCA(FAM)A(DSP)A(BHQ1)CCAAACAACAAAG-3'.
[0014] A kit for analyzing human-derived components, comprising the above-mentioned primers, or a combination of primers and probes.
[0015] A method for rapidly detecting human-derived components based on real-time fluorescent recombinase polymerase amplification technology comprises the following steps:
[0016] (1) Extracting DNA from the sample to be tested;
[0017] (2) Using real-time fluorescent recombinase polymerase chain reaction amplification technology, the above-mentioned primers or primer and probe combination, or kit are used to amplify and detect the DNA of the sample to be tested, and judging whether the sample to be tested contains human components based on the fluorescence curve.
[0018] Furthermore, the RPA reaction system included 2 μL of DNA template, 1 μL of each 10 μmol / L upstream and downstream primers, 0.3 μL of 10 μmol / L probe, 12.5 μL of hydration solution, 1.25 μL of magnesium acetate solution, and finally made up to 25 μL with sterile deionized water.
[0019] Furthermore, the RPA reaction temperature was 37°C and the amplification time was 20 min.
[0020] Application of the above primers, primer and probe combinations, kits or methods in forensic species identification, food safety analysis or air aerosol pollution detection.
[0021] The technical principles of the present invention are as follows:
[0022] The recombinase polymerase amplification (RPA) used in the present invention is also known as Recombinase Aid Amplification (RAA), Multienzyme Isothermal RPAid Amplification (MIRA) and body temperature amplification technology (STAMP). This technology is a technology for realizing exponential amplification of nucleic acids under constant temperature conditions. It is called a nucleic acid detection technology that can replace PCR. Its main principle is that the protein-DNA complex formed by the combination of recombinase and primer can find homologous sequences in double-stranded DNA. Once the primer locates the homologous sequence, a chain exchange reaction will occur and DNA synthesis will be initiated. The target area on the template is exponentially amplified, and the replaced DNA chain is combined with a single strand binding protein (SSB) to prevent further replacement. The RPA experiment can specifically identify and amplify the DNA fragments of the target sample at a constant and relatively low temperature (37-39°C), and nucleic acid detection can be completed within 5-20 minutes. The key to RPA detection technology lies in the design of amplification primers and probes. RPA primers are longer than general PCR primers, so commonly used PCR primers are usually not directly used in RPA technology. The length of RPA primers usually needs to reach 30-36 bases. Too short will affect its amplification speed and detection sensitivity. At the same time, the designed fluorescent-labeled probe is combined with its amplification product. When the probe is cleaved by the exonuclease, a fluorescent signal is emitted, and the amplification process can be monitored in real time. Compared with conventional PCR experiments, the entire experimental operation process of RPA is relatively simple, the detection process does not require temperature control, the equipment requirements are relatively low, and the reaction time is greatly shortened, so it is suitable for rapid detection of samples.
[0023] Beneficial effects of the present invention:
[0024] 1. The recombinase polymerase amplification technology involved in the present invention has the advantages of being fast, accurate and simple to operate. In the embodiment of the present invention, after the RPA system is configured, it only needs to directly add the DNA sample extracted in the early stage, and the entire amplification time only takes 20 minutes. Compared with the conventional PCR that must go through the three steps of denaturation, annealing and extension, the overall detection time is shorter and the operation steps are simple.
[0025] 2. The RPA system provided by the present invention has a sensitivity of up to 0.003125 ng. No amplification curve appears in any animal samples, and the presence of human DNA can be successfully detected in a mixed sample of 1:1000 (human DNA: animal DNA). It has good species specificity. Therefore, the RPA system can accurately identify human components in low-template samples and can be used in forensic medicine, food safety and other fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 It is a comparison chart of the sensitivity results of three pairs of RPA primers;
[0027] Figure 2 This is a schematic diagram of positive control amplification of the RPA detection method;
[0028] Figure 3 This is a schematic diagram of negative control amplification of the RPA detection method;
[0029] Figure 4 This is a schematic diagram of the results of RPA detecting unknown samples;
[0030] Figure 5 This is the result diagram of species-specific validation of the RPA system;
[0031] Figure 6 This is the result diagram of the sensitivity study of the RPA system;
[0032] Figure 7 This is the result of the mixed sample sensitivity study of the RPA system. DETAILED DESCRIPTION
[0033] The specific implementation modes of the present invention are described below so that those skilled in the art can understand the present invention. However, it should be clear that the present invention is not limited to the scope of the specific implementation modes. For those of ordinary skill in the art, as long as various changes are within the spirit and scope of the present invention as defined and determined by the attached claims, these changes are obvious, and all inventions and creations utilizing the concept of the present invention are protected.
[0034] Example 1 Primer and probe design
[0035] 1. Primer design
[0036] The cytochrome b gene (Cyt b) on human mitochondrial DNA was selected from the NCBI website. This sequence is a region commonly used for species identification in practice and has good species specificity. Since the RPA technology requires the amplified product to be 100-200bp in length, a 148bp sequence on Cyt b (from 15601 to 15748) was selected.
[0037] According to the selected 148bp sequence and the requirements of RPA technology for primers, primers were designed using the primer-BLAST website. The primer design conditions were: primer length 30-36bp, GC content 40-60%, and product length 70-200bp. Based on this condition, a pair of primers (F1 and R1 in Table 1) were screened out; the primer conditions were further modified, the GC content was changed to 30-70%, and other conditions were unchanged, and 5 pairs of primers were screened out. Finally, 2 pairs of primers were selected, and their product length was more than 100bp (F2, F3, R2, and R3 in Table 1).
[0038] For the three selected primer pairs, 0.1 ng / μL human genomic DNA standard (9947A) was used to dilute it 2 times with sterile deionized water, and the dilutions (0.05, 0.025, 0.0125, 0.00625, 0.003125, 0.0015625 ng / μL) were used for different RPA systems constructed by the three primer pairs, and the experimental repeatability was tested (each experiment was repeated three times). The results are shown in the figure. Figure 1 As shown, the sensitivity of the three primer pairs was comparable, and the F1R1 primer pair showed good repeatability, so F1 and R1 were finally selected as the primer pair for subsequent studies.
[0039] Table 1 Primers and probes used
[0040] name Sequence (from 5' to 3' end) F1 CCTATTACTATCCATCCTCATCCTAGCAAT F2 CTATTACTATCCATCCTCATCCTAGCAATAAT F3 CTATTACTATCCATCCTCATCCTAGCAATAA R1 CTAGGAGTCAATAAAGTGATTGGCTTAGTG R2 CTAGGAGTCAATAAAGTGATTGGCTTAGTG R3 TAGGAGTCAATAAAGTGATTGGCTTAGTGG exo-P TCATCCTAGCAATAATCCCCATCCTCCA(FAM)A(THF)A(BHQ1)CCAAACAACAAAG
[0041] 2. Probe design
[0042] According to the selected 148 bp and RPA probe requirements, a probe with a fluorescent group FAM, a quenching group BHQ1, a tetrahydrofuran dSpacer and a modification group C3-spacer at the 3' end was designed. The probe sequence is shown in Table 1.
[0043] Example 2 RPA system construction
[0044] The RPA nucleic acid amplification kit (fluorescence type) was purchased from Hangzhou Zhongce Biotechnology Co., Ltd., and its system included: 2 μL DNA template, 1 μL each of 10 μmol / L upstream and downstream primers, 0.3 μL of 10 μmol / L probe, 12.5 μL hydration solution, 1.25 μL magnesium acetate solution, 6.95 μL sterile deionized water, and a total volume of 25 μL.
[0045] The detection process based on the above RPA system is as follows:
[0046] (1) Configure the RPA system according to the above reaction system
[0047] First prepare a mix containing A Buffer, upstream primer (10μM), downstream primer (10μM), and probe (10μM), mix well and add to the detection unit tube containing reaction dry powder, then add 2μL of the DNA sample to be tested and 6.95μL of water to the detection unit tube, finally add 1.25μL of B Buffer to the detection unit tube cap, cover the tube cap, turn it upside down and gently shake it for 5-6 times to mix thoroughly, and centrifuge it at low speed for 10s.
[0048] During the operation, it is necessary to ensure that the unit tubes are capped at the same time and tightly. After centrifugation for 10 seconds, the detection unit tubes should be immediately placed in the ABI-7500 fluorescence detector.
[0049] (2) Analysis using ABI7500
[0050] Open the ABI7500 instrument and software to create a new experiment. Select the instrument type and then select the standard quantitative curve. Set the fluorescent group FAM and the quenching group BHQ1 according to the designed probe, select the location of the sample in the instrument, set the reaction program according to the conditions in Table 2, and start the reaction after saving.
[0051] Table 2 ABI-7500 setting conditions
[0052] step temperature Time / Cycle Number of cycles Fluorescence signal acquisition Preheat 37℃ 60s 1 no Amplification 37℃ 30s 40 yes
[0053] In the detection method constructed by the present invention, positive and negative controls are required for each amplification. The DNA sample used in the positive control is 0.1 ng / μL human genome DNA standard (9947A), and the sample used in the negative control is sterile deionized water. The amplification curves of the positive and negative controls are shown in Figure 2. Figure 2 and Figure 3 As shown in the figure (the three curves in the figure represent the results of three repeated experiments). In actual detection, the amplification results of the sample (amplification curve and CT value) are compared with the positive and negative controls to determine whether human DNA exists. Figure 4 As shown, the amplification curve of the unknown sample is similar to that of the positive control, so it is judged that human DNA exists.
[0054] Example 3 System specificity and sensitivity verification
[0055] 1. Species-specific verification:
[0056] Based on the RPA system and detection method constructed in Example 2, a series of animal samples (mouse, sheep, rabbit, dog, cat, duck, pig, chicken, cattle, fish) at a concentration of 0.1 ng / μL were used for RPA amplification to verify the species specificity of the primers and probes of the system. The results are as follows: Figure 5As shown in the figure, no amplification curves appeared in any of the animal samples, indicating that the primers and probes of this system had good species specificity.
[0057] 2. System sensitivity detection
[0058] (1) A 0.1 ng / μL human genomic DNA standard (9947A) was serially diluted 2-fold with sterile deionized water. The dilutions (0.05, 0.025, 0.0125, 0.00625, 0.003125, 0.0015625 ng / μL) were used to evaluate the sensitivity of the RPA system. The results are shown in Figure 6 As shown, the sensitivity of the system can reach 0.003125 ng (the three curves in the figure represent the results of three repeated experiments).
[0059] (2) Mixed samples were prepared using 0.1 ng / μL human genomic DNA standard (9947A) and different concentrations of animal samples (the samples used were chicken DNA, with concentrations of 0.1 ng / μL, 1 ng / μL, 10 ng / μL, 100 ng / μL, and 1000 ng / μL, respectively). The mixing ratios were 1:1, 1:10, 1:100, 1:1000, and 1:10000. The test results are as follows: Figure 7 As shown, the presence of human DNA can be successfully detected at a mixing ratio of 1:1000 (the three curves in the figure represent the results of three repeated experiments), indicating that it has excellent sensitivity and specificity and can be used for the detection, identification and analysis of human components in unknown samples.
Claims
1. A primer and probe combination for human component analysis, characterized in that: The nucleotide sequences of the primers are shown in SEQ ID NOs. 1 and 2; there is an overlap of 13 bases between the 5' end of the probe and the primer pair, and the modification group at the 3' end of the probe is C3-spacer; The specific sequence of the probe is: 5'-TCATCCTAGCAATAATCCCCATCCTCCA / FAM-T / A / DSP / A / BHQ1-T / CCAA ACAACAAAG-3'.
2. A kit for analyzing human-derived components, characterized in that: The kit comprises the primer and probe combination of claim 1.
3. A method for rapid detection of human-derived components based on real-time fluorescent recombinase polymerase amplification technology, characterized in that: The following steps are involved: (1) Extract DNA from the sample to be tested; (2) Using real-time fluorescent recombinase polymerase chain reaction amplification technology, the primer and probe combination of claim 1 or the kit of claim 2 is used to amplify and detect the DNA of the sample to be tested, and judging whether the sample to be tested contains human components based on the fluorescence curve.
4. The method according to claim 3, characterized in that The RPA reaction system included 2 μL of DNA template, 1 μL of 10 μmol / L upstream and downstream primers, 0.3 μL of 10 μmol / L probe, 12.5 μL of hydration solution, 1.25 μL of magnesium acetate solution, and finally made up to 25 μL with sterile deionized water.
5. The method according to claim 3, characterized in that: The RPA reaction temperature was 37°C and the amplification time was 20 min.
6. Use of the primer and probe combination of claim 1, the kit of claim 2, or the method of any one of claims 3 to 4 in forensic species identification, food safety analysis, or air aerosol pollution detection.
